Intellia Therapeutics Bolsters Talent Amid Market Volatility to Advance CRISPR Therapies
Intellia Therapeutics continues to make strategic moves to bolster its position in the gene editing space, despite facing market volatility and challenges, with a focus on attracting top talent and advancing its pipeline of CRISPR-based therapies.
3 minutes to read